Search Results - Jianling Bi

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Cover Image

    Advantages of Tyrosine Kinase Anti-Angiogenic Cediranib over Bevacizumab: Cell Cycle Abrogation and Synergy with Chemotherapy by Jianling Bi, Garima Dixit, Yuping Zhang, Eric J. Devor, Haley A. Losh, Andreea M. Newtson, Kristen L. Coleman, Donna A. Santillan, Thorsten Maretzky, Kristina W. Thiel, Kimberly K. Leslie

    Published 2021
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: